Apart from a possible true no-effect of the increase in Ang II formation on ischemic stroke severity in human patients, the validity of grouping antihypertensive drugs based on the formation of Ang II should perhaps be reconsidered. The gene discussed is AGT; the disease is ischemic stroke.